000			01967 a2200541 4500
005			20250518093329.0
264		0	_c20200911
008			202009s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdz382 _2doi
040			_aNLM _beng _cNLM
100	1		_aBielack, S S
245	0	0	_aRapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _c11 2019
300			_aviii31-viii35 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFibrosarcoma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aOncogene Proteins, Fusion _xgenetics
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aPyrazoles _xtherapeutic use
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aSalvage Therapy
700	1		_aCox, M C
700	1		_aNathrath, M
700	1		_aApel, K
700	1		_aBlattmann, C
700	1		_aHoll, T
700	1		_aJenewein, R
700	1		_aKlenk, U
700	1		_aKlothaki, P
700	1		_aMüller-Abt, P
700	1		_aOrtega-Lawerenz, S
700	1		_aReynolds, M
700	1		_aScheer, M
700	1		_aSimon-Klingenstein, K
700	1		_aStegmaier, S
700	1		_aTupper, R
700	1		_aVokuhl, C
700	1		_avon Kalle, T
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 30 Suppl 8 _gp. viii31-viii35
856	4	0	_uhttps://doi.org/10.1093/annonc/mdz382 _zAvailable from publisher's website
999			_c30791814 _d30791814